Company Increases Quarterly Dividend by 20% and
Issues Earnings Guidance for 2014
U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of
outpatient physical therapy clinics, today reported results for the
fourth quarter and year ended December 31, 2013.
U.S. Physical Therapy’s net income attributable to common
shareholders from continuing operations for the three months ended
December 31, 2013 was $3.9 million and diluted earnings per share
were $0.32.
Net income attributable to common shareholders from continuing
operations for the year 2013 was $17.5 million and diluted earnings
per share were $1.45.
In the third quarter of 2013, the Company sold the remaining
piece of its former Physician Services business, which was treated
as a discontinued operation for financial reporting purposes.
During the year the Company incurred losses from physician services
of $4.8 million, or $0.40 per diluted share, which represents the
operational loss of the business and write-down of its net assets,
inclusive of intangible assets, less sale proceeds net of
appropriate reserves. Net income attributable to common
shareholders, inclusive of discontinued operations for 2013, was
$12.7 million, or $1.05 per diluted share.
Fourth Quarter 2013 Compared to Fourth
Quarter 2012 from Continuing Operations
- Net revenues increased 10.0% from
$62,381,000 in the fourth quarter of 2012 to $68,605,000 in the
fourth quarter of 2013, due to an increase in visits of 11.1% from
574,000 to 638,000 offset by a decrease in the average net patient
revenue per visit of $.85 to $105.47 from $106.32.
- Total clinic operating costs were
$52,467,000, or 76.5% of net revenues, in the fourth quarter of
2013, as compared to $48,002,000, or 76.9% of net revenues, in the
2012 period. The increase was attributable to $4,497,000 in
operating costs of new clinics opened or acquired in the past 12
months offset by a reduction in operating costs of $32,000 for
those clinics opened or acquired prior to the past 12 months. The
fourth quarter 2013 results include a pre-tax charge of $850,000
for an estimated refund due to a payor for overpayments to a
partnership clinic group over several years. Without that expense
operating costs in the recent quarter for older clinics would have
decreased by $882,000. Total clinic salaries and related costs,
including that from new clinics, were 53.2% of net revenues in the
recent quarter versus 53.9% in the 2012 period. Rent, clinic
supplies, contract labor and other costs as a percentage of net
revenues were 21.5% for the recent quarter versus 20.9% in the 2012
period. The provision for doubtful accounts as a percentage of net
revenues was 1.4% for the 2013 period and 1.9% in the 2012
period.
- The gross margin for the fourth quarter
of 2013 increased by 12.2% to $16,138,000 from $14,379,000 in the
fourth quarter of 2012. The gross margin percentage was 23.5% for
the 2013 quarter as compared to 23.1% for the comparable 2012
period.
- Corporate office costs were $6,766,000
in the fourth quarter of 2013 as compared to $6,078,000 in the 2012
fourth quarter. Corporate office costs were 9.9% of net revenues in
the 2013 period and 9.7% in the 2012 period.
- Operating income for the recent quarter
increased by 12.9% to $9,372,000 compared to $8,301,000 in the 2012
fourth quarter.
- Interest expense was $140,000 in the
fourth quarter of 2013 versus $108,000 in the fourth quarter of
last year.
- The provision for income taxes for the
2013 period includes $569,000 which represents an adjustment of
$393,000 related to the year 2012 from the completion of the income
tax reconciliation between the tax returns and provision for 2012
(“tax true-up”) and $156,000 to increase the 2013 effective tax
rate to 40%. The provision for income taxes as a percentage of
income before taxes less net income attributable to non-controlling
interest was 33.6% in the 2012 period. For the 2012 period, the
income tax provision was reduced by $350,000 related to the write
down of an intercompany loan that was charged to
additional-paid-in-capital and is tax deductible.
- Net income attributable to
non-controlling interests, inclusive of discontinued operations,
was $1,893,000 in the recent quarter as compared to $1,750,000 in
the year earlier period.
- Net income attributable to common
shareholders for the three months ended December 31, 2013 was
$3,903,000 compared to $4,230,000 for the three months ended
December 31, 2012. Diluted earnings per share were $0.32 for the
2013 period and $0.35 for the 2012 period.
- Same store visits increased 4.0% for de
novo and acquired clinics open for one year or more while revenue
increased 2.4% as the average net rate per visit decreased by
$1.60.
Year 2013 Compared to Year 2012 from
Continuing Operations Unless Otherwise Noted
- Net revenues increased 5.8% from
$249,651,000 in 2012 to $264,058,000 in 2013, due to a 5.5%
increase in visits from 2,314,000 to 2,441,000 and an increase in
the average net patient revenue per visit to $105.83 from $105.50
in 2012.
- Total clinic operating costs were
$199,357,000 or 75.5% of net revenues in 2013 as compared to
$186,741,000 or 74.8% of net revenues in 2012. The increase was
primarily attributable to $10,220,000 in operating costs of new
clinics opened or acquired in the past 12 months and an increase in
operating costs of $6,270,000 for those clinics opened or acquired
in 2012 offset by a decrease in operating costs of $3,874,000 for
those clinics opened or acquired prior to 2012. Included in the
2013 results is a pre-tax charge of $850,000 related to an
estimated refund due to a payor for overpayments to a partnership
clinic group over several years. Without this charge, operating
costs for those clinics opened or acquired prior to 2012 would have
been reduced by $4,724,000. Clinic salaries and related costs were
53.7% of net revenues in 2013 versus 52.7% in 2012. Rent, clinic
supplies, contract labor and other costs as a percentage of net
revenues were 20.0% for 2013 versus 20.1% in 2012. The provision
for doubtful accounts as a percentage of net revenues was 1.7% for
2013 versus 1.9% in 2012.
- Gross margin for 2013 was $64,701,000,
or 24.5%, compared to $62,910,000, or 25.2%, for 2012.
- Corporate office costs were $25,931,000
in 2013 as compared to $24,504,000 in 2012. Corporate office costs
were 9.8% of net revenues in both 2013 and 2012.
- Operating income for 2013 was
$38,770,000 compared to $38,406,000 in 2012.
- Interest expense was $538,000 in 2013
versus $557,000 in 2012.
- The provision for income taxes as a
percentage of income before taxes less net income attributable to
non-controlling interests was 41.1% in 2013 and 38.1% in 2012. For
2013, the provision for income taxes for the 2013 period includes
an adjustment of $393,000 related to the tax true-up for 2012. The
provision for income taxes as a percentage of income before taxes
less net income attributable to non-controlling interests is 40%
for 2013 and expected to be at a comparable tax rate in 2014. For
the 2012 period, the income tax provision was reduced by $350,000
related to the write down of an intercompany loan that was charged
to additional-paid-in-capital and is tax deductible.
- Net income attributable to
non-controlling interests, inclusive of discontinued operations,
was $8,273,000 in 2013 as compared to $8,284,000 in 2012.
- Net income attributable to common
shareholders was $17,492,000 in 2013 as compared to $18,212,000 in
2012. Diluted earnings per share were $1.45 for 2013 as compared to
$1.53 for 2012.
- Same store visits increased 1.5% and
same store revenue increased 1.0% while the average net rate per
visit was down $0.52.
Larry McAfee, Chief Financial Officer, noted, “The Company
experienced a nice pick-up in patient volume in the fourth quarter.
Unfortunately this was somewhat overshadowed by the combined $.09
per share impact from the payor refund and the tax adjustment.”
Chris Reading, Chief Executive Officer, said, “2013 was in many
ways a challenging year largely as a result of government
reimbursement cuts, however, I am proud of our team for rising to
the challenge. We were able to finish 2013 with same store volume
growth for both the quarter as well as the year. Additionally, this
was by far the best development year in the Company’s history. We
made five acquisitions adding 42 clinics. These new partnerships,
in combination with our strong base of existing partners, position
us well for 2014. Given the continued challenges for standalone
physical therapy practices, we expect to continue to provide a good
home to those owners who wish to partner with a company which will
robustly support them.”
Management Earnings
Guidance
U.S. Physical Therapy’s management expects the Company’s
earnings from continuing operations for the year 2014 to be in the
range of $18.8 million to $19.6 million in net income and $1.54 to
$1.60 in diluted earnings per share. This guidance range is net of
approximately a $.07 to $.08 earnings per share impact from MPPR
and Sequestration being in effect for 12 months in 2014 as compared
to nine months in 2013. Additionally through March 5, 2014,
management estimates that although new patient referrals have been
solid, due to the adverse weather conditions in many parts of the
country more than 10,000 patient visits have been cancelled since
January 1st resulting in an estimated earnings impact of at least
$.04 per share. Management’s guidance range represents projected
earnings from existing operations only and excludes future
potential acquisitions. The annual guidance figures will not be
updated unless there is a material development that causes
management to believe that earnings will be significantly outside
the given range.
U.S. Physical Therapy Declares
Quarterly Dividend
The Company is increasing its quarterly dividend rate by 20%
from $.10 to $.12 per share. The first quarterly dividend of 2014
for $.12 per share will be paid on April 4 to shareholders of
record as of March 19.
Fourth Quarter and Year 2013 Conference
Call
U.S. Physical Therapy's management will host a conference call
at 10:30 a.m. Eastern Time, 9:30 a.m. Central Time, on Thursday,
March 6, 2014 to discuss the Company’s Quarter and Year Ended
December 31, 2013 results. Interested parties may participate in
the call by dialing 1-888-335-5539 or 973-582-2857 and enter
reservation number 34126042 approximately 10 minutes before the
call is scheduled to begin. To listen to the live call via
web-cast, go to the Company's website at www.usph.com at least 15
minutes early to register, download and install any necessary audio
software. The conference call will be archived and can be accessed
until May 6, 2014.
Forward-Looking
Statements
This press release contains statements that are considered to be
forward-looking within the meaning under Section 21E of the
Securities Exchange Act of 1934, as amended. These statements
contain forward-looking information relating to the financial
condition, results of operations, plans, objectives, future
performance and business of our Company. These statements (often
using words such as “believes”, “expects”, “intends”, “plans”,
“appear”, “should” and similar words) involve risks and
uncertainties that could cause actual results to differ materially
from those we project. Included among such statements are those
relating to new clinics, availability of personnel and the
reimbursement environment. The forward-looking statements are based
on our current views and assumptions and actual results could
differ materially from those anticipated in such forward-looking
statements as a result of certain risks, uncertainties, and
factors, which include, but are not limited to:
- changes as the result of government
enacted national healthcare reform;
- changes in Medicare guidelines and
reimbursement or failure of our clinics to maintain their Medicare
certification status;
- business and regulatory conditions
including federal and state regulations;
- changes in reimbursement rates or
payment methods from third party payors including government
agencies and deductibles and co-pays owed by patients;
- revenue and earnings expectations;
- general economic conditions;
- availability and cost of qualified
physical and occupational therapists;
- personnel productivity;
- competitive, economic or reimbursement
conditions in our markets which may require us to reorganize or
close certain operations and thereby incur losses and/or closure
costs including the possible write-down or write-off of goodwill
and other intangible assets;
- maintaining adequate internal
controls;
- availability, terms, and use of
capital;
- acquisitions, purchase of non
controlling interests (minority interests) and the successful
integration of the operations of the acquired businesses; and
- weather and other seasonal
factors.
Many factors are beyond our control. Given these uncertainties,
you should not place undue reliance on our forward-looking
statements. Please see our periodic reports filed with the
Securities and Exchange Commission for more information on these
factors. Our forward-looking statements represent our estimates and
assumptions only as of the date of this press release. Except as
required by law, we are under no obligation to update any
forward-looking statement, regardless of the reason the statement
is no longer accurate.
About U.S. Physical Therapy,
Inc.
Founded in 1990, U.S. Physical Therapy, Inc. operates 472
outpatient physical and occupational therapy clinics in 43 states.
The Company's clinics provide preventative and post-operative care
for a variety of orthopedic-related disorders and sports-related
injuries, treatment for neurologically-related injuries and
rehabilitation of injured workers. In addition to owning and
operating clinics, the Company manages 18 physical therapy
facilities for third parties, including hospitals and physician
groups.
More information about U.S. Physical Therapy, Inc. is available
at www.usph.com. The information included on that website is not
incorporated into this press release.
U.S. PHYSICAL THERAPY, INC. AND
SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NET INCOME (IN THOUSANDS,
EXCEPT PER SHARE DATA) Three Months Ended
December 31, Year Ended December 31, 2013 2012 2013 2012
Net patient revenues $ 67,256 $ 61,052 $ 258,283 $ 244,100
Other revenues 1,349 1,329 5,775
5,551 Net revenues 68,605 62,381 264,058
249,651 Clinic operating costs: Salaries and related costs
36,522 33,630 141,840 131,604 Rent, clinic supplies, contract labor
and other 14,726 13,051 52,887 50,102 Provision for doubtful
accounts 994 1,186 4,384 4,824 Closure costs 225
135 246 211 Total clinic
operating costs 52,467 48,002
199,357 186,741 Gross margin 16,138
14,379 64,701 62,910 Corporate office costs 6,766
6,078 25,931 24,504
Operating income from continuing operations 9,372
8,301 38,770 38,406 Interest and other income, net 2 2 7 6
Interest expense (140 ) (108 ) (538 )
(557 ) Income before taxes from continuing operations 9,234
8,195 38,239 37,855 Provision for income taxes 3,438
2,163 12,236 11,215
Net income from continuing operations including
non-controlling interests 5,796 6,032 26,003 26,640 Discontinued
operations, net of tax (42 ) (239 ) (5,007 )
(423 ) Net income including non-controlling interests 5,754
5,793 20,996 26,217 Less: net income attributable to
non-controlling interests (1,893 ) (1,750 )
(8,273 ) (8,284 ) Net income attributable to common
shareholders $ 3,861 $ 4,043 $ 12,723 $ 17,933
Basic earnings per share attributable to common
shareholders: From continuing operations $ 0.32 $ 0.36 $ 1.45 $
1.54 From discontinued operations - (0.02 )
(0.40 ) (0.02 ) Basic $ 0.32 $ 0.34 $
1.05 $ 1.52 Diluted earnings per share
attributable to common shareholders: From continuing operations $
0.32 $ 0.35 $ 1.45 $ 1.53 From discontinued operations -
(0.01 ) (0.40 ) (0.02 ) Diluted $ 0.32
$ 0.34 $ 1.05 $ 1.51 Shares used
in computation: Basic 12,103 11,911
12,063 11,804 Diluted
12,117 12,013 12,082
11,904 Dividends declared per common share $ 0.10
$ 0.49 $ 0.40 $ 0.76 Earnings
attributable to common shareholders: From continuing operations $
3,903 $ 4,230 $ 17,492 $ 18,212 From discontinued operations
(42 ) (187 ) (4,769 ) (279 ) $ 3,861 $
4,043 $ 12,723 $ 17,933
U.S. PHYSICAL THERAPY, INC. AND
SUBSIDIARIES
CONSOLIDATED EARNINGS PER SHARE (IN
THOUSANDS, EXCEPT PER SHARE DATA) Three Months
Ended Year Ended December 31, December 31, 2013 2012 2013 2012
Earnings attributable to common shareholders: From
continuing operations $ 3,903 $ 4,230 $ 17,492 $ 18,212 From
discontinued operations (42 ) (187 ) (4,769 )
(279 ) $ 3,861 $ 4,043 $ 12,723 $
17,933 Basic earnings per share attributable to
common shareholders: From continuing operations $ 0.32 $ 0.36 $
1.45 $ 1.54 From discontinued operations -
(0.02 ) (0.40 ) (0.02 ) Basic $ 0.32 $ 0.34
$ 1.05 $ 1.52 Diluted earnings per
share attributable to common shareholders: From continuing
operations $ 0.32 $ 0.35 $ 1.45 $ 1.53 From discontinued operations
- (0.01 ) (0.40 ) (0.02 )
Diluted $ 0.32 $ 0.34 $ 1.05 $ 1.51
Shares used in computation: Basic earnings per share -
weighted-average shares 12,103 11,911 12,063 11,804 Effect of
dilutive securities - Stock options 14 102
19 100 Denominator for diluted
earnings per share - adjusted weighted-average shares 12,117
12,013 12,082 11,904
U.S. PHYSICAL THERAPY, INC. AND
SUBSIDIARIES
CONSOLIDATED BALANCE
SHEETS(IN THOUSANDS, EXCEPT PER SHARE DATA)
December 31, December 31, 2013 2012 ASSETS Current assets:
Cash and cash equivalents $ 12,898 $ 11,671 Patient accounts
receivable, less allowance for doubtful accounts of $1,430 and
$1,595, respectively 30,820 25,973 Accounts receivable - other,
less allowance for doubtful accounts of $198 and $514, respectively
1,844 1,703 Other current assets 4,098 5,975
Total current assets 49,660 45,322 Fixed assets:
Furniture and equipment 38,965 36,316 Leasehold improvements
21,891 20,858 60,856 57,174 Less accumulated
depreciation and amortization 45,896 44,158
14,960 13,016 Goodwill 143,955 100,188 Other intangible
assets, net 14,479 12,146 Other assets 1,081
1,042 $ 224,135 $ 171,714 LIABILITIES
AND SHAREHOLDERS' EQUITY Current liabilities: Accounts
payable - trade $ 1,722 $ 1,732 Accrued expenses 20,625 14,116
Current portion of notes payable 825 459
Total current liabilities 23,172 16,307 Notes payable 650
175 Revolving line of credit 40,000 17,400 Deferred rent 996 894
Other long-term liabilities 4,196 2,279
Total liabilities 69,014 37,055 Commitments and
contingencies Redeemable non-controlling interests 4,104 -
Shareholders' equity:
U.S. Physical Therapy, Inc. shareholders'
equity:
Preferred stock, $.01 par value, 500,000 shares authorized, no
shares issued and outstanding - - Common stock, $.01 par value,
20,000,000 shares authorized, 14,315,882 and 14,129,651 shares
issued, respectively 143 141 Additional paid-in capital 40,569
37,489 Retained earnings 119,206 111,321 Treasury stock at cost,
2,214,737 shares (31,628 ) (31,628 )
Total U.S. Physical Therapy, Inc.
shareholders' equity
128,290 117,323 Noncontrolling interests 22,727
17,336 Total equity 151,017
134,659 $ 224,135 $ 171,714
U.S. PHYSICAL THERAPY, INC. AND
SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH
FLOWS(IN THOUSANDS) Year Ended December 31, 2013
2012
OPERATING ACTIVITIES Net income including
noncontrolling interests $ 20,996 $ 26,218 Adjustments to reconcile
net income including noncontrolling interests to net cash provided
by operating activities: Depreciation and amortization 5,562 5,287
Provision for doubtful accounts 4,384 4,848 Gain on purchase price
settlement - - Equity-based awards compensation expense 2,743 2,102
Loss (gain) on sale of business and fixed assets 7,335 175 Excess
tax benefit from exercise of stock options (695 ) (1,351 ) Deferred
income tax 2,369 3,738 Other - - Changes in operating assets and
liabilities: Increase in patient accounts receivable (5,389 )
(1,663 ) Increase in accounts receivable - other (5 ) (561 )
(Increase) decrease in other assets 1,803 (585 ) (Decrease)
increase in accounts payable and accrued expenses 4,833 (340 )
(Decrease) increase in other liabilities 859
1,381 Net cash provided by operating activities 44,795
39,249
INVESTING ACTIVITIES Purchase of fixed assets
(4,637 ) (4,234 ) Purchase of businesses, net of cash acquired
(46,628 ) (7,929 ) Acquisitions of noncontrolling interests (1,876
) (2,244 ) Sale of noncontrolling interests 233 239 Settlement of
purchase price - - Proceeds on sale of business and fixed assets,
net 459 64 Net cash used in investing
activities (52,449 ) (14,104 )
FINANCING ACTIVITIES
Distributions to noncontrolling interests (9,164 ) (9,332 ) Cash
dividends to shareholders (4,838 ) (9,017 ) Purchase and retire of
common stock - - Proceeds from revolving line of credit 150,800
79,900 Payments on revolving line of credit (128,200 ) (86,000 )
Payment of notes payable (459 ) (434 ) Tax benefit from stock
options exercised 695 1,351 Other 47 75
Net cash provided by (used in) financing activities 8,881 (23,457 )
Net increase in cash and cash equivalents 1,227 1,688 Cash
and cash equivalents - beginning of period 11,671
9,983 Cash and cash equivalents - end of period $
12,898 $ 11,671
SUPPLEMENTAL DISCLOSURES OF
CASH FLOW INFORMATION Cash paid during the period for: Income
taxes $ 4,111 $ 6,361 Interest $ 352 $ 639 Non-cash investing and
financing transactions during the period: Purchase of business -
seller financing portion $ 1,300 $ 350
U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIESRECAP OF
CLINIC COUNT Number of Date
Clinics December 31, 2010 392 March 31, 2011
397 June 30, 2011 398 September 30, 2011 420 December 31, 2011 416
March 31, 2012 414 June 30, 2012 419 September 30, 2012 423
December 31, 2012 431 March 31, 2013 441 June 30, 2013 449
September 30, 2013 447 December 31, 2013 472
U.S. Physical Therapy, Inc.Larry McAfee, (713) 297-7000Chief
Financial OfficerorChris Reading, (713) 297-7000Chief Executive
OfficerorThe Ruth GroupStephanie Carrington, (646) 536-7017
US Physical Therapy (NYSE:USPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
US Physical Therapy (NYSE:USPH)
Historical Stock Chart
From Jul 2023 to Jul 2024